OptiNose Surges Premarket Following Acquisition Agreement With Paratek Pharmaceuticals for Up to $330 Million
In This Article:
OptiNose (OPTN) shares were up more than 61% in premarket activity Thursday after the company overni
Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.